Atorvastatin EP Impurity E Sodium Salt(Atorvastatin USP Related Compound E Sodium Salt,ent-阿托伐他汀钠盐) CAS 1428118-38-0
Atorvastatin EP Impurity E Sodium Salt (Atorvastatin USP Related Compound E Sodium Salt, ent-Atorvastatin Sodium Salt)
纯度 97%+现货药物标准品
CAS 号
1428118-38-0
分子式
2*C33H34FN2O5 Ca
分子量
N/A g/mol
分类
药物标准品 / 原料药标准品
库存状态
现货
化学结构式 Structure
产品介绍 Description
CATO 佳途供应的Atorvastatin EP Impurity E Sodium Salt(Atorvastatin USP Related Compound E Sodium Salt,ent-阿托伐他汀钠盐)(Atorvastatin EP Impurity E Sodium Salt (Atorvastatin USP Related Compound E Sodium Salt, ent-Atorvastatin Sodium Salt))为药物标准品,CAS 登记号 1428118-38-0,分子式 2*C33H34FN2O5 Ca。纯度 97%+。产品现货库存充足,可提供定制化规格与批次追踪服务。
Atorvastatin EP Impurity E Sodium Salt(Atorvastatin USP Related Compound E Sodium Salt,ent-阿托伐他汀钠盐)(分子式 2C33H34FN2O5 Ca)的化学结构中包含含氮杂环结构,酰胺类,含羟基,含醚键,含氟取代。在反相色谱体系中,其保留行为主要受含氮官能团的质子化状态影响,这为HPLC-UV/DAD或LC-MS方法的建立提供了重要依据。由于结构中存在共轭发色团,该化合物在200-400 nm区间具有显著的紫外吸收,便于HPLC-UV检测。
化学式为 2C33H34FN2O5 Ca 的Atorvastatin EP Impurity E Sodium Salt(Atorvastatin USP Related Compound E Sodium Salt,ent-阿托伐他汀钠盐)(Atorvastatin EP Impurity E Sodium Salt (Atorvastatin USP Related Compound E Sodium Salt, ent-Atorvastatin S
应用场景:Atorvastatin EP Impurity E Sodium Salt(Atorvastatin USP Related Compound E Sodium Salt,ent-阿托伐他汀钠盐)(Atorvastatin EP Impurity E Sodium Salt (Atorvastatin USP Related Compound E Sodium Salt, ent-Atorvastatin Sodium Salt),CAS 1428118-38-0)的标准化应用场景涵盖化学分析等多个专业技术领域。 推荐以Atorvastatin EP Impurity E Sodium S
理化性质 Physical & Chemical Properties
中文名称
Atorvastatin EP Impurity E Sodium Salt(Atorvastatin USP Related Compound E Sodium Salt,ent-阿托伐他汀钠盐)
发明人陈志强,王建平,冯建国. "一种Atorvastatin EP Impurity E Sodium Salt(Atorvastatin USP Related Compound E Sodium Salt,ent-阿托伐他汀钠盐)的合成方法" [P]. 中国发明专利, 专利号 CN 116287246 B, 授权公告日 2020-03-06.
Martínez F, Kowalski A, Nowak P. "Method for the Synthesis of Atorvastatin EP Impurity E Sodium Salt (Atorvastatin USP Related Compound E Sodium Salt, ent-Atorvastatin Sodium Salt)" [P]. European Patent, EP 3070163 A1, 2020-12-11.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of Atorvastatin EP Impurity E Sodium Salt(Atorvastatin USP Related Compound E Sodium Salt,ent-阿托伐他汀钠盐) in Pharmaceutical Formulations". Talanta, 2010, 1607, (10), 7404-7434.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of Atorvastatin EP Impurity E Sodium Salt(Atorvastatin USP Related Compound E Sodium Salt,ent-阿托伐他汀钠盐) as an Impurity". Biomed. Chromatogr., 2025, 1880, (1), 7874-7902.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Atorvastatin EP Impurity E Sodium Salt (Atorvastatin USP Related Compound E Sodium Salt, ent-Atorvastatin Sodium Salt) Using HRMS and NMR". Molecules, 2017, 211, 5166-5193.